Vimarsana
Biggest News Aggregation in the World

Page 2 - Classi Recall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Classi Recall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Classi Recall Today - Breaking & Trending Today

Diabetes Dialogue: News on Abbott Readers & CMS Expansion of CGM Availability - Vimarsana News

Diabetes Dialogue: News on Abbott Readers & CMS Expansion of CGM Availability

Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss the implications of increased CGM access through a recent CMS expansion and take a deep dive into the latest Abbott news, including dispelling misconceptions surrounding the recall announcement.

Stoney Acres Farm recalls frozen pizza - Vimarsana News

Stoney Acres Farm recalls frozen pizza

Stoney Acres Farm, out of Athens, Wisc. is issuing a voluntary Class I recall of some of its Stoney Pepperoni pizzas sold at retail stores.

Source: wdio.com
FDA Issues Class I Recall of Abbott FreeStyle Readers for Risk of Overheating, Fire - Vimarsana News

FDA Issues Class I Recall of Abbott FreeStyle Readers for Risk of Overheating, Fire

Announced on April 6, the recall, which is the most serious of its kind, includes all Readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems distributed from November 2017-February 2023, which totals more than 4 million devices in the US.

FDA Class 1 Recall: Batteries for CARESCAPE 2860 Ventilator - Vimarsana News

FDA Class 1 Recall: Batteries for CARESCAPE 2860 Ventilator

The backup power source for the CARESCAPE Ventilator may drain unexpectedly fast, prompting concern.

Celltrion's rapid COVID tests hit with 2nd Class I recall in a month - Vimarsana News

Celltrion's rapid COVID tests hit with 2nd Class I recall in a month

Celltrion’s range of COVID-19 diagnostic kits have once again fallen under the FDA’s microscope, just weeks after the regulator cracked down on sales of a version of the company's rapid antigen tes